Abiomed (ABMD) Reports In-Line Q3 EPS
Tweet Send to a FriendGet Alerts ABMD Hot Sheet
Price: $23.33 +0.95%
Revenue Growth %: +17.2%
Financial Fact:
Nonoperating Income (Expense), Total: 325K
Today's EPS Names:
LBIX, ESEA, ISS, More
Revenue Growth %: +17.2%
Financial Fact:
Nonoperating Income (Expense), Total: 325K
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade ABMD Now!
Abiomed, Inc. (NASDAQ: ABMD) reported Q3 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $38.3 million versus the consensus estimate of $38.04 million.
For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Abiomed to Present at UBS Global Health Care Conference
- Euroseas Ltd. (ESEA) Posts Q1 Loss of 10c/Share
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
